Do you want to read an article? Please log in or register.
Interpretation of the evidence for the efficacy and safety of statin therapy
Diabetes - General
Related content
COMMENTED
Lipids
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Lancet.
Cholesterol Treatment Trialists' Collaboration
doi: org/10.1016/S0140-
Type 2 DiabetesGlycemic Control
Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes
Diabetes Obes Metab.
Handelsman Y, Mathieu C, Del Prato S, Johnsson E, Kurlyandskaya R, Iqbal N, Garcia-Sanchez R, Rosenstock J
doi: 10.1111/dom.13594.
Type 2 Diabetes
Long-term efficacy and safety of combined insulin and GLP-1 therapy: evidence from the LEADER trial
Diabetes Obes Metab.
Tack CJ, Jacob S, Desouza C, Bain SC, Buse JB, Nauck MA, Petrie JR, Poulter NR, Pratley RE, Stegmann HVBK, Bosch-Traberg H, Startseva E, Zinman B, LEADER Publication Committee on behalf of the LEADER Trial Investigators.
doi: 10.1111/dom.13826.
Type 2 Diabetes
BALANCING CARDIOVASCULAR BENEFIT AND DIABETOGENIC HARM OF THERAPY WITH STATINS: REAL-WORLD EVIDENCE FROM ITALY
★ 1
Recommended by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Res Clin Pract.
Corrao G, Monzio Compagnoni M, Cantarutti A, Rea F, Merlino L, Catapano AL, Mancia G
doi: 10.1016/j.diabres.2020.108197.
Diabetes - General
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Lancet Diabetes Endocrinol.
Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM, Murphy SA, Kuder JF, Gouni-Berthold I, Lewis BS, Handelsman Y, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR
doi: 10.1016/
COMMENTED
Type 2 Diabetes
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Pediatr Diabetes
Shankar RR, Zeitler P, Deeb A, Jalaludin MY, Garcia R, Newfield RS, Samoilova Y, Rosario CA, Shehadeh N, Saha CK, Zhang Y, Zilli M, Scherer LW, Lam RLH, Golm GT, Engel SS, Kaufman KD
doi: 10.1111/pedi.13279
Diabetes - GeneralType 2 Diabetes
Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial
Diabetes Obes Metab.
Harris SB, Kocsis G, Prager R, Ridge T, Chandarana K, Halladin N, Jabbour S
doi: 10.1111/dom.12892.
COMMENTED
Diabetes - GeneralType 2 DiabetesGlycemic Control
A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study
Diabetes Obes Metab.
Scott R, Morgan J, Zimmer Z, Lam RLH, O'Neill EA, Kaufman KD, Engel SS, Raji A
doi: 10.1111/dom.13473.
Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl
Am J Cardiol.
Piao ZH, Jin L, Kim JH, Ahn Y, Kim YJ, Cho MC, Kim CJ, Kim HS, Liu B, Jeong MH; Other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators
doi: 10.1016/j.amjcard.